- Motley Fool•1 hour ago
Catalysts at IBM, Briggs & Stratton, and Gilead Sciences could make it the perfect time to step up and buy shares in these companies.
- Investopedia•6 hours ago
Biotech stocks had a rough year in 2016, overall. The new year has brought new optimism among some investors, but there are still reasons to be cautious.
- Motley Fool•yesterday
Big pharma is reeling from President-elect Trump's press-conference comments that the industry is "getting away with murder."
GILD : Summary for Gilead Sciences, Inc. - Yahoo Finance
Gilead Sciences Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||72.38 x 600|
|Ask||72.40 x 100|
|Day's Range||71.80 - 72.82|
|52 Week Range||70.83 - 103.10|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||6.69|
|Dividend & Yield||1.88 (2.57%)|
|1y Target Est||N/A|